גליומות - טפינלר פלוס מקיניסט
Glioblastoma and all gliomas – Tafinlar plus Mekinist, a durable benefit
Background - Glioblastoma and BRAF BRAFV600E mutations are rarely encountered in adult glioblastoma with an incidence ranging from less than 1% to 8%. But young adults, i.e. 17 to 35…